Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureus

31 Jan 2023

Abstract excerpt

Staphylococcus aureus (S. aureus) is a worldwide leading versatile pathogen that causes a wide range of serious infections. The emergence of antimicrobial resistance against S. aureus resulted in an urgent need to develop new antimicrobials in the new era. The methicillin-resistant S. aureus (MRSA) prevalence in hospital and community settings necessitates the discovery of novel anti-pathogenic agents....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial biofilms and quorum sensing
Share to Microbial Metabolism and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36830188
DOI: 10.3390/antibiotics12020277

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureusPMID 36830188Read ↗

Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus.Semantic proximity Read ↗

Staphyloxanthin Biosynthesis and Virulence in <em>Staphylococcus aureus</em>: Emerging Opportunities for Anti-Virulence TherapySemantic proximity Read ↗

Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approachSemantic proximity Read ↗

Exploring Staphylococcus aureus Virulence Factors; Special Emphasis on StaphyloxanthinSemantic proximity Read ↗

Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: An in vitro and in silico approachSemantic proximity Read ↗

Mechanism of staphylococcal resistance to clinically relevant antibioticsSemantic proximity Read ↗

Anti-virulence potential of iclaprim, a novel folic acid synthesis inhibitor, against Staphylococcus aureusSemantic proximity Read ↗

Disarming Staphylococcus aureus: Review of Strategies Combating This Resilient Pathogen by Targeting Its VirulenceSemantic proximity Read ↗

Potential antivirulence and antibiofilm activities of sub-MIC of oxacillin against MDR S. aureus isolates: an in-vitro and in-vivo studySemantic proximity Read ↗

Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapySemantic proximity Read ↗

Critical Assessment of the Prospects of Quorum-Quenching Therapy for Staphylococcus aureus InfectionSemantic proximity Read ↗

Chemical and Biomolecular Insights into the Staphylococcus aureus Agr Quorum Sensing System: Current Progress and Ongoing ChallengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.